Back
Columbia Seligman Premium Technology Growth Fund Vs. Sanara MedTech, Inc. Industry Stock Comparison
Sell
44
STK
Columbia Seligman Premium Technology Growth Fund
Last Price:
$36.30
Seasonality Move:
0.87%
Sell
40
SMTI
Sanara MedTech, Inc.
Last Price:
$24.18
Seasonality Move:
42.72%
Sell
44
Columbia Seligman Premium Technology Growth Fund (STK)
is a Sell
Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?
-
The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $36.26. The Score for STK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
STK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Sanara MedTech, Inc. (SMTI)
is a Sell
Is Sanara MedTech, Inc. a Buy, Sell or Hold?
-
The current Sanara MedTech, Inc. [SMTI] share price is $24.21. The Score for SMTI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SMTI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STK Stock Price Chart
What is Columbia Seligman Premium Technology Growth Fund's stock price today?
-
The Columbia Seligman Premium Technology Growth Fund share price today is $36.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STK is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMTI Stock Price Chart
What is Sanara MedTech, Inc.'s stock price today?
-
The Sanara MedTech, Inc. share price today is $24.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMTI is experiencing slight selling pressure.
STK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.68 | Buy |
| Relative Strength Index (14 RSI): | 49.32 | Sell |
| Chaikin Money Flow: | 50580 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.62 - 37.38) | Buy |
| Bollinger Bands (100): | (32.36 - 37.5) | Buy |
SMTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.56 | Buy |
| Relative Strength Index (14 RSI): | 52.38 | Buy |
| Chaikin Money Flow: | -13535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.98 - 24.06) | Buy |
| Bollinger Bands (100): | (23.55 - 33.11) | Sell |
STK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.96 | Buy |
| 20-day SMA: | 36.25 | Buy |
| 50-day SMA: | 36.81 | Sell |
| 200-day SMA: | 31.93 | Buy |
| 8-day EMA: | 18.8 | Buy |
| 20-day EMA: | 9.19 | Buy |
| 50-day EMA: | 4 | Buy |
| 200-day EMA: | 1.05 | Buy |
SMTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.64 | Sell |
| 20-day SMA: | 22.44 | Buy |
| 50-day SMA: | 25.29 | Sell |
| 200-day SMA: | 29.12 | Sell |
| 8-day EMA: | 12.84 | Buy |
| 20-day EMA: | 6.29 | Buy |
| 50-day EMA: | 2.74 | Buy |
| 200-day EMA: | 0.72 | Buy |
Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sanara MedTech, Inc. Earnings Growth & SMTI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Columbia Seligman Premium Technology Growth Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sanara MedTech, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||